{"transactions":[{"id":2430302,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:54:07.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":256500,"price":2.81,"value":720765.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":256500,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":256500},"source":{"system":"sec-edgar","filing":"0001447028-22-000008","document":"wf-form4_164271923431244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000008/wf-form4_164271923431244.xml","form_type":"4"}},{"id":2854287,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options","published_at":"2021-02-17T22:08:31.000Z","date":"2021-02-13","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":250000,"derivative":{"exercise_price":4.33,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001447028-21-000014","document":"wf-form4_161359969444382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000014/wf-form4_161359969444382.xml","form_type":"4"}},{"id":3022373,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-09-25T20:06:44.000Z","date":"2020-09-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on February 14, 2020, the trading day immediately preceding the date the performance based option grant wasapproved by the Executive Compensation and Human Resources Committee of the Board of Directors (the \"Committee\") of Arbutus Biopharma Corporation, subject to both shareholder approval of anamendment to the Registrant's 2016 Omnibus Share and Incentive Plan (the \"Plan Amendment\") and the fulfillment of certain performance criteria."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Registrant's shareholders approved the Plan Amendment on May 28, 2020. On September 23, 2020, the Committee determined that the performance criteria had been met."}],"balance_after":50000,"derivative":{"exercise_price":3.35,"expiration_date":"2020-02-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001447028-20-000144","document":"wf-form4_160106438963827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000144/wf-form4_160106438963827.xml","form_type":"4"}},{"id":3262958,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options","published_at":"2020-02-19T13:04:53.000Z","date":"2020-02-17","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":150000,"derivative":{"exercise_price":3.35,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001447028-20-000029","document":"wf-form4_158211747537119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000029/wf-form4_158211747537119.xml","form_type":"4"}},{"id":3612040,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-05T23:09:35.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":137500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in three equal annual installments beginning March 1, 2020."}],"balance_after":137500,"derivative":{"exercise_price":4.57,"expiration_date":"2029-03-01","underlying":"Common Shares","underlying_shares":137500},"source":{"system":"sec-edgar","filing":"0001123292-19-000438","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000112329219000438/edgar.xml","form_type":"4"}},{"id":3793406,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":131218,"kind":"person","name":"Picchio Gaston","position":1,"cik":"0001755014","reported_name":"Picchio Gaston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2018-10-10T18:20:39.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on 10/8/2019; 1/3 on 10/8/2020; and 1/3 on 10/8/2021."}],"balance_after":200000,"derivative":{"exercise_price":9.38,"expiration_date":"2028-10-08","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-18-003919","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000156761918003919/doc1.xml","form_type":"4"}}]}